A Novel Homozygous Mutation Causing Complete TYK2 Deficiency, with Severe Respiratory Viral Infections, EBV-Driven Lymphoma, and Jamestown Canyon Viral Encephalitis

J Clin Immunol. 2023 Nov;43(8):2011-2021. doi: 10.1007/s10875-023-01580-x. Epub 2023 Sep 11.

Abstract

Autosomal recessive tyrosine kinase 2 (TYK2) deficiency is characterized by susceptibility to mycobacterial and viral infections. Here, we report a 4-year-old female with severe respiratory viral infections, EBV-driven Burkitt-like lymphoma, and infection with the neurotropic Jamestown Canyon virus. A novel, homozygous c.745C > T (p.R249*) variant was found in TYK2. The deleterious effects of the TYK2 lesion were confirmed by immunoblotting; by evaluating functional responses to IFN-α/β, IL-10, and IL-23; and by assessing its scaffolding effect on the cell surface expression of cytokine receptor subunits. The effects of the mutation could not be pharmacologically circumvented in vitro, suggesting that alternative modalities, such as hematopoietic stem cell transplantation or gene therapy, may be needed. We characterize the first patient from Canada with a novel homozygous mutation in TYK2.

Keywords: EBV lymphoma; Inborn error of immunity; Jamestown Canyon virus; TYK2; viral encephalitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Encephalitis, Viral*
  • Female
  • Herpesvirus 4, Human
  • Humans
  • Lymphoma*
  • Mutation / genetics
  • TYK2 Kinase / genetics
  • Virus Diseases*

Substances

  • TYK2 Kinase
  • TYK2 protein, human

Supplementary concepts

  • Tyrosine Kinase 2 Deficiency